VERV
Verve Therapeutics
VERV
VERV
Delisted
VERV was delisted on the 24th of July, 2025.
92 hedge funds and large institutions have $1.06B invested in Verve Therapeutics in 2022 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 39 increasing their positions, 23 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
less funds holding
Funds holding: →
14% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 22
36% less capital invested
Capital invested by funds: $1.66B → $1.06B (-$598M)
83% less call options, than puts
Call options by funds: $212K | Put options by funds: $1.25M
Holders
92
Holding in Top 10
3
Calls
$212K
Puts
$1.25M
Top Buyers
| 1 | +$21.8M | |
| 2 | +$20.9M | |
| 3 | +$20.5M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$9.88M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$8.44M |
Top Sellers
| 1 | -$36.4M | |
| 2 | -$16.5M | |
| 3 | -$10.8M | |
| 4 |
NIP
Nicholas Investment Partners
Rancho Santa Fe,
California
|
-$10M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$9.32M |